Spermosens AB (SPERM.ST) Research

Spermosens AB, a Swedish company established in 2018 and based in Lund, focuses on the creation, advancement, and commercialization of diagnostic technologies for the medical and healthcare industries. The firm specifically provides solutions for male infertility, offering both diagnostic tools and fertility treatment options within the in-vitro fertilization (IVF) sector. A central development is their JUNO-Checked device, which accurately measures the interaction and binding strength between sperm and egg cells. This crucial data allows for the tailoring of fertility treatments to each individual's specific needs.

Market snapshot

Symbol
SPERM.ST
Price
$0.01
Day change
+4.00%
Market cap
$33.0M
P/E ratio
-2.54x
52-week range
0.0042-0.012
Sector
Healthcare
Industry
Medical - Diagnostics & Research

Peer companies

  • Aptahem AB (publ) (APTA.ST)
  • Chordate Medical Holding AB (publ) (CMH.ST)
  • Episurf Medical AB (publ) (EPIS-B.ST)
  • Fluicell AB (publ) (FLUI.ST)
  • ODI Pharma AB (ODI.ST)
  • Prostatype Genomics AB (publ) (PROGEN.ST)
  • Qlife Holding AB (publ) (QLIFE.ST)
  • Quia Pharma AB (publ) (QUIA.ST)

Open Spermosens AB (SPERM.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.